Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Dalteparin in Hip Replacement
NCT00398216Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of edoxaban in venous thromboembolism (VTE) (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Adjudicated Incidence of Venous Thromboembolism. Started May 2006; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00398216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398216.